MedPath

Mechanisms of Myocardial Infarction in Women With Non Obstructive Coronary Artery Disease

Conditions
Myocardial Infarction
Interventions
Procedure: cardiac imajing
Registration Number
NCT01953029
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The objective of our work to determine the mechanisms of myocardial infarction in women without obstructive coronary artery disease.

Detailed Description

Cardiovascular disease is the leading cause of death for women. Acute coronary syndrome (ACS) is usually characterized by a sudden erosion of the endothelial wall or rupture of a plaque.However, women with ACS are less likely than men to have either classic symptoms or obstructive coronary artery disease but paradoxically have a worse prognosis. Different data from the literature indicate that there may be different pathophysiological mechanisms, afflicting men and women somewhat differently.Between 5% and 30% of patients with ACS undergoing coronary angiography are found to have non visible or non obstructive coronary disease (NOCD). This is 2-3 times more common in women than in men. Several pathogenetic mechanism of myocardial infarction (MI) in the absence of obstructive coronary artery disease (OCD) have been postulated, including among others atherosclerosis with plaque disruption that does not lead to luminal occlusion ,endothelial dysfunction, vasospasm , distal microembolization and microvascular dysfunction. However the data are extremely limited.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Women ≥ 18 years old, not pregnant
  • with acute non ST elevation myocardial infarction (admitted within 12 hours from beginning of symptoms)
  • who are candidates for coronary arteriography during the hospitalization. -
Exclusion Criteria

*Women with troponin elevation caused by other causes -

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
non obstructive coronary diseasecardiac imajingnon obstructive coronary disease
Primary Outcome Measures
NameTimeMethod
MORTALITY1 YEAR
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam Heath Care Campus

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath